RMTI: Stock Quote & Summary Data |
Company Description (as filed with the SEC)
Rockwell Medical Technologies, Inc., incorporated in the state of Michigan in 1996, manufactures hemodialysis concentrate solutions and dialysis kits, and we sell, distribute and deliver these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (“ESRD”). ESRD is an advanced stage of chronic kidney disease (“CKD”) characterized by the irreversible loss of kidney function. Without properly functioning kidneys, a patient’s body cannot get rid of excess water and toxic waste products. Without frequent and ongoing dialysis treatments, these patients would not survive. Our dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient’s bloodstream. ... More ...
Links to all Rockwell Medical Technologies, Inc. (RMTI) Pages
Stock Analysis
Fundamentals
Holdings
/Ownership
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $-1.21 |
| Quarterly EPS Est: | -0.48 |
| PEG Ratio: | .00 |
| Mean Recommendation: View Summary/View All |
1 |
Data is provided by Zacks Investment Research
Home
Search NASDAQ
Search Web

Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
